A new study has shown that variation in the microbiota of the human gut impacts the pharmacokinetics of tamoxifen and thus ...

Tamoxifen is a common and important treatment to prevent breast cancer from recurring. A new study shows that variation in a ...

A new study has shown that variation in the microbiota of the human gut impacts the pharmacokinetics of tamoxifen and thus the effectiveness of the drug.

Conference Call Information Olema will hold a conference call to discuss these data with the investment community on Tuesday, December 10, 2024, at 8:00 a.m. ET/7:00 a.m. CT. Register to join the ...

Shanghai Ark Biopharmaceutical (ArkBio) has concluded enrolment and dosing for a Phase I trial of fully human monoclonal ...

The report "Bioresorbable Polymers Market by Type (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polylactic-co-glycolic ...

Technologies announced the completion of enrollment in its Phase 2 Study of PL8177, a potent melanocortin-1 receptor agonist, in ...

IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Reaches Alignment with FDA Regarding Phase 3 Trial Plan On November 25, 2024, Imunon, Inc. (NASDAQ:IMNN) announced it had reached alignment with ...

An impaired driving criminal case sparked the researcher's curiosity over whether nasal sprays can have the same intoxicating ...

Prescription of Neurontin (gabapentin) and other gabapentinoids has increased partly because they are viewed as a safer ...

SINGAPORE--University of Cologne Advances Research with Cutting-Edge Liquid Cooling from KAYTUS and NEC Deutschland ...